91Ó°ÊÓ

Researchers at the University of Washington and Harvard University analyzed records of breast cancer screening and diagnostic evaluations ("Mammogram Cancer Scares More Frequent Than Thought," USA TODAY, April 16,1998 ). Discussing the benefits and downsides of the screening process, the article states that although the rate of falsepositives is higher than previously thought, if radiologists were less aggressive in following up on suspicious tests, the rate of false-positives would fall, but the rate of missed cancers would rise. Suppose that such a screening test is used to decide between a null hypothesis of \(H_{0}:\) no cancer is present and an alternative hypothesis of \(H_{a}:\) cancer is present. (Although these are not hypotheses about a population characteristic, this exercise illustrates the definitions of Type I and Type II errors.) a. Would a false-positive (thinking that cancer is present when in fact it is not) be a Type I error or a Type II error? b. Describe a Type I error in the context of this problem, and discuss the consequences of making a Type I error. c. Describe a Type II error in the context of this problem, and discuss the consequences of making a Type II error. d. Recall the statement in the article that if radiologists were less aggressive in following up on suspicious tests, the rate of false-positives would fall but the rate of missed cancers would rise. What aspect of the relationship between the probability of a Type I error and the probability of a Type II error is being described here?

Step by step solution

01

a. Identifying False-Positive Error Type

A false-positive is when the test indicates that cancer is present when it actually isn't. In hypothesis testing, a Type I error occurs when the null hypothesis is rejected when it is actually true. In this context, the null hypothesis is \(H_{0}:\) no cancer is present. Thus, a false-positive would be a Type I error.

02

b. Description and Consequences of Type I Error

In the context of this problem, a Type I error occurs when the screening test suggests that cancer is present, leading to the rejection of the null hypothesis \(H_{0}:\) no cancer is present, when in fact the patient does not have cancer. The consequences of this error include unnecessary stress, additional diagnostic tests, potential harm from invasive procedures, and increased healthcare costs for the patient and healthcare system.

03

c. Description and Consequences of Type II Error

In the context of this problem, a Type II error occurs when the screening test suggests that no cancer is present, leading us to fail to reject the null hypothesis when the alternative hypothesis \(H_{a}:\) cancer is present is true. In other words, the patient has cancer, but the test does not detect it. The consequences of this error include a delay in diagnosis and treatment, potentially leading to more advanced cancer, lower chances of successful treatment, and a higher risk of death.

04

d. Relationship between Type I and Type II Error Probabilities

The article mentioned in the exercise states that if radiologists were less aggressive in following up on suspicious tests, the rate of false-positives (Type I errors) would fall, but the rate of missed cancers (Type II errors) would rise. This describes the fundamental trade-off between Type I and Type II errors in hypothesis testing. When we increase the threshold for evidence required to reject the null hypothesis, we decrease the probability of committing a Type I error, but increase the probability of committing a Type II error. Conversely, if we lower the threshold for evidence required to reject the null hypothesis, we increase the probability of committing a Type I error while decreasing the probability of committing a Type II error. In this particular context, being less aggressive in follow-up exams would reduce the rate of false cancer diagnoses, but increase the rate of undetected cancers.

Unlock Step-by-Step Solutions & Ace Your Exams!

• Full Textbook Solutions

  Get detailed explanations and key concepts

• Unlimited Al creation

  Al flashcards, explanations, exams and more...

• Ads-free access

  To over 500 millions flashcards

• Money-back guarantee

  We refund you if you fail your exam.

Over 30 million students worldwide already upgrade their learning with 91Ó°ÊÓ!

Key Concepts

These are the key concepts you need to understand to accurately answer the question.

Type I Error

A Type I error in hypothesis testing occurs when we reject the null hypothesis (\(H_{0}\): no cancer is present) when it is actually true. In the context of a breast cancer screening, this means the test suggests a patient has cancer when, in fact, they don't. Such scenarios are referred to as "false-positives."

False-positives can carry significant emotional and practical consequences. Patients may experience unnecessary stress and anxiety due to a mistaken diagnosis of cancer. Furthermore, this error often leads to additional, more invasive diagnostic procedures that are both costly and uncomfortable. These can sometimes even result in harm from unnecessary medical treatments.

In a broader perspective, high rates of Type I errors strain healthcare systems, increasing costs due to unnecessary follow-up tests and treatments. Hence, it's vital to design screening tests to minimize these errors, always weighing this against the risk of making Type II errors.

Type II Error

A Type II error is the mistake of failing to reject the null hypothesis when the alternative hypothesis is true. In this scenario, it means that the screening test fails to detect cancer when it is actually present in the patient. This is an underdiagnosing issue.

**Consequences of Type II Error**

• Delayed Diagnosis: The main risk of a Type II error is that cancer remains undetected, leading to a delay in its diagnosis.
• Advanced Progression: Untreated cancer can progress to more advanced stages, making it harder to treat effectively.
• Increased Mortality Risk: Delayed treatment generally results in a poorer prognosis and may increase the risk of cancer-related mortality.

Balancing these errors is crucial in medical testing. Overly cautious tests can miss true cases of cancer if they are not designed to be sensitive enough, illustrating why a delicate balance must exist between identifying true positives and avoiding false negatives.

False-Positive

In the context of our breast cancer screening example, a false-positive is an outcome where the test indicates the presence of cancer when there is none. This is a manifestation of a Type I error and can have several implications.

**Understanding False-Positives**

• False-positives understandably cause emotional distress for individuals, as the prospect of having cancer is a serious concern.
• Procedurally, they necessitate additional diagnostic tests to refute the initial results, which can be costly and uncomfortable.
• The accumulated effect of false-positives on a healthcare system includes increased resource allocation to follow-up tests that turn out unnecessary.

There is a natural trade-off in hypothesis testing between reducing false-positives and missing actual cases of disease (Type II errors). When testing is too conservative in diagnosing ailments, it might reduce false alarms but may also miss true positives, endangering those affected. This balance highlights the need for careful calibration of medical tests, ensuring they provide reliable detection while minimizing unnecessary alarms.